Anal Canal Clinical Trials

1 recruiting

Anal Canal Trials at a Glance

8 actively recruiting trials for anal canal are listed on ClinicalTrialsFinder across 6 cities in 7 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Boston, Camperdown, and Charleston. Lead sponsors running anal canal studies include Bicara Therapeutics, Grupo Espanol Multidisciplinario del Cancer Digestivo, and AHS Cancer Control Alberta.

Browse anal canal trials by phase

Treatments under study

About Anal Canal Clinical Trials

Looking for clinical trials for Anal Canal? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Anal Canal trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Anal Canal clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Not Applicable

Mepilex Lite Dressings for the Treatment of Acute Radiation Dermatitis of Anal Canal Skin

Acute Radiation DermatitisRectal Cancer, RadiotherapyAnal Pain+1 more
Qianfoshan Hospital274 enrolled1 locationNCT06837831
Recruiting

Gynecologic Extramammary Paget's Disease

Paget Disease, ExtramammaryExtramammary Paget DiseaseExtramammary Paget's Disease+6 more
Mayo Clinic100 enrolled1 locationNCT03564483
Recruiting
Phase 2

Dynamic ctDNA Assessment in Cervical and Anal Canal Tumors: Optimizing Follow-up and Clinical Outcomes

HPV-Related Anal Squamous Cell CarcinomaHPV-Related Cervical CarcinomaHPV-Related Carcinoma+2 more
Instituto do Cancer do Estado de São Paulo150 enrolled1 locationNCT06640283
Recruiting
Phase 2

Inguinal Node Sparing Radiotherapy For Patients With Early Stage Anal Cancer

Anal Canal Cancer
AHS Cancer Control Alberta45 enrolled1 locationNCT05040815
Recruiting
Not Applicable

Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers

Metastatic Gastroesophageal Junction AdenocarcinomaMetastatic Hepatocellular CarcinomaStage IV Hepatocellular Carcinoma AJCC v8+41 more
University of California, San Francisco28 enrolled2 locationsNCT04221893
Recruiting
Phase 1

Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

Head and Neck Squamous Cell CarcinomaSquamous Cell Carcinoma of Anal Canal
Bicara Therapeutics292 enrolled20 locationsNCT04429542
Recruiting
Not Applicable

IMRT Versus IMPT With Concurrent Chemotherapy for Locally Advanced Anal Canal Cancer

Malignant Neoplasm of Anal Canal
Tata Memorial Centre108 enrolled1 locationNCT06630793
Recruiting
Phase 2

Tiraglolumab Atezolizumab and Chemoradiotherapy in Localized Anal Carcinoma (TIRANUS)

Squamous Cell Carcinoma of the Anal Canal
Grupo Espanol Multidisciplinario del Cancer Digestivo45 enrolled15 locationsNCT05661188